Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.
| Website | http://www.gravitoncorp.com |
| Revenue | $7.2 million |
| Employees | 43 (21 on RocketReach) |
| Founded | 2023 |
| Address | 125 West End Ave Suite 701, New York, New York 10023, US |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Therapeutics, Clinical Stage, Pharmaceutical, Drug Discovery, Biopharma, Therapeutic Compounds, Drug Development, Clinical Trials, Life Sciences, Cell Signaling, Biomedical Research, Molecular Biology, Cancer Research, Rare Diseases, Private Equity |
| Competitors | Amgen, AstraZeneca, Novartis, Regeneron, Gilead Sciences, Biogen, Bristol Myers Squibb, Roche, Vertex Pharmaceuticals +43 more (view full list) |
Looking for a particular Graviton Bioscience employee's phone or email?
Graviton Bioscience Questions
The Graviton Bioscience annual revenue was $7.2 million in 2026.
Christie Matsui is the Chief People Officer of Graviton Bioscience.
21 people are employed at Graviton Bioscience.
Graviton Bioscience is based in New York, New York.
Top Graviton Bioscience Employees
-
Christie Matsui
Chief People Officer at Graviton Bioscience
New York, NY, US33 -
Heeyoung Park
Vice President, Regulatory at Graviton Bioscience
New York, NY, US25+ -
Alia Jebara
VP, Medical and Pharmacovigilance at Graviton Bioscience
New York, NY, US23 -
Ed Chen
Vice President, Drug Substance at Graviton Bioscience
New York, NY, US14 -
15+
-
Alexandra Zanin-Zhorov
Senior Vice President, Translational Medicine at Graviton Bioscience
New York, United States2 -
Jean Kim
SVP, Head of Chemistry at Graviton Bioscience
Princeton, NJ, US13 -
Andrew Wojcik
VP Clinical Quality and Compliance at Graviton Bioscience
Scotch Plains, NJ, US13
G2Crowd Trusted
300K+
Plugin Users
